Antifungal therapy, an everlasting battle | SpringerLink Skip to main content Advertisement
SpringerLink Account Menu Find a journal Publish with us Track your research Search Cart …

Medical mycology has always been somewhat overshadowed by bacteriology, and if judged
simply by volume will never reach the status of its big sister in the field of infectious diseases …

The high rates of morbidity and mortality caused by fungal infections are associated with the
current limited antifungal arsenal and the high toxicity of the compounds. Additionally …

Human mycoses can be categorized as superficial, localized, or disseminated. Superficial
mycoses are generally confined to the skin and nails, whereas localized mycoses include …

This book is designed to provide a comprehensive but insightful examination of antifungal
therapy in the changing clinical milieu of modern medicine. It is an update from the original …

For over the last three decades, extensive testing of antifungal compounds in clinical trials
has been essential to the development of treatment guidelines for the most common …

Since the 1950s there has been an increase in the incidence of invasive fungal disease. The
first successful systemically administered antifungal drug, amphotericin B, was introduced in …

Skip the header click to show the menu Menu Cart Login Login/Register Institutional Access
Access Options Enter words / phrases / DOI / ISBN / keywords / authors / etc Search Advanced …

This second volume of PDR SPECIAL TOPICS contains five review articles, covering nearly
the entire field of fungal diseases in humans as well as therapeutic approaches. The main …

In many ways, fungal diseases are forgotten or neglected. Given the significantly lower
frequency compared to similar bacterial etiologies across the spectrum of infectious …